Watch CELU. Know when insiders buy.
One email the day a filing lands. Free.
CELU
Celularity Inc
1.44
−0.10 −6.49%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
42
WATCH · shorts 42
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $41.7MP/E —DIV YIELD —FCF YIELD —REV TTM $26.6M −51.0%NET INCOME −$91.7MNET DEBT $10.9M52W 0.60 – 2.35SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 · Dec 31derived | $4.1M | −77.4% | -79.7% | −$22.1M | −$24.4M | — | -0.85 | −$5.1M | — | — | Apr 30 |
| Q3 2025 · Sep 30 | $5.3M | −43.2% | 26.1% | −$12.9M | −$23.1M | — | -0.88 | −$4.2M | — | — | Nov 14 |
| Q2 2025 · Jun 30 | $5.7M | −52.6% | 8.6% | −$15.9M | −$24.5M | — | -1.02 | −$999K | — | — | Nov 14 |
| Q1 2025 · Mar 31 | $11.4M | −22.2% | 68.9% | −$10.5M | −$19.8M | — | -0.84 | −$3M | — | — | Nov 14 |
| Q4 2024 · Dec 31derived | $18.1M | +49.7% | 59.5% | −$9.3M | −$13.3M | −239.2% | -0.59 | $1.6M | $91K | $1.5M | Apr 30 |
| Q3 2024 · Sep 30 | $9.3M | +145.5% | 58.2% | −$11.5M | −$16.1M | — | -0.73 | −$144K | $0 | −$144K | Nov 14 |
| Q2 2024 · Jun 30 | $12.1M | +312.2% | 82.5% | −$10.2M | −$6.5M | — | -0.30 | −$3.4M | $31K | −$3.5M | Nov 14 |
| Q1 2024 · Mar 31 | $14.7M | +273.1% | 88.8% | −$7.4M | −$22M | — | -1.03 | −$4.4M | $39K | −$4.4M | Nov 14 |
| Q4 2023 · Dec 31derived | $12.1M | — | 20.7% | $13.3M | $9.5M | — | 0.84 | −$4.3M | $580K | −$4.9M | May 8 |
| Q3 2023 · Sep 30 | $3.8M | — | 4.9% | −$99.3M | −$93.9M | — | -4.98 | −$8.3M | $228K | −$8.6M | Dec 6 |
| Q2 2023 · Jun 30 | $2.9M | — | 72.7% | −$42.5M | −$47.9M | — | -2.72 | −$11M | $31K | −$11.1M | Nov 7 |
| Q1 2023 · Mar 31 | $3.9M | — | 49.1% | −$63.9M | −$64M | — | -4.12 | −$15M | $209K | −$15.2M | Oct 16 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $26.6M | 24.4% | −$61.3M | −$91.7M | -345.4% | -3.59 | −$13.3M | — | — | — | — |
| FY2024 · to Dec 31 | $54.2M | 72.4% | −$38.4M | −$57.9M | -106.8% | -2.64 | −$6.4M | $161K | −$6.6M | — | — |
| FY2023 · to Dec 31 | $22.8M | 29.7% | −$192.3M | −$196.3M | -862.0% | -11.02 | −$38.7M | $1M | −$39.7M | — | — |
| FY2022 · to Dec 31 | $18M | -9.4% | −$25.6M | $14.2M | 79.0% | 0.95 | −$137.9M | $5.2M | −$143.1M | — | — |
| FY2021 · to Dec 31 | $21.3M | 54.8% | −$109.1M | −$100.1M | -469.3% | -1.49 | −$110.1M | $6.2M | −$116.3M | — | — |
| FY2020 · to Dec 31 | $14.3M | 65.5% | −$151.9M | −$208.2M | -1458.4% | -11.31 | −$63.2M | $27.8M | −$91M | $256K | — |
Every number comes from Celularity Inc's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.